Home Cart 0 Sign in  
X

[ CAS No. 1975-52-6 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 1975-52-6
Chemical Structure| 1975-52-6
Chemical Structure| 1975-52-6
Structure of 1975-52-6 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1975-52-6 ]

Related Doc. of [ 1975-52-6 ]

Alternatived Products of [ 1975-52-6 ]

Product Details of [ 1975-52-6 ]

CAS No. :1975-52-6 MDL No. :MFCD00007371
Formula : C8H7NO4 Boiling Point : -
Linear Structure Formula :- InChI Key :DJRFJAVPROZZFL-UHFFFAOYSA-N
M.W : 181.15 Pubchem ID :519683
Synonyms :

Calculated chemistry of [ 1975-52-6 ]

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.12
Num. rotatable bonds : 2
Num. H-bond acceptors : 4.0
Num. H-bond donors : 1.0
Molar Refractivity : 47.19
TPSA : 83.12 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.93 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.06
Log Po/w (XLOGP3) : 2.08
Log Po/w (WLOGP) : 1.6
Log Po/w (MLOGP) : 0.84
Log Po/w (SILICOS-IT) : -0.47
Consensus Log Po/w : 1.02

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -2.48
Solubility : 0.596 mg/ml ; 0.00329 mol/l
Class : Soluble
Log S (Ali) : -3.46
Solubility : 0.0635 mg/ml ; 0.000351 mol/l
Class : Soluble
Log S (SILICOS-IT) : -1.54
Solubility : 5.24 mg/ml ; 0.0289 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 2.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.78

Safety of [ 1975-52-6 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H317-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1975-52-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1975-52-6 ]
  • Downstream synthetic route of [ 1975-52-6 ]

[ 1975-52-6 ] Synthesis Path-Upstream   1~30

  • 1
  • [ 89-71-4 ]
  • [ 59382-59-1 ]
  • [ 1975-52-6 ]
Reference: [1] Recueil des Travaux Chimiques des Pays-Bas, 1901, vol. 20, p. 169
  • 2
  • [ 118-90-1 ]
  • [ 1975-50-4 ]
  • [ 1975-52-6 ]
Reference: [1] Recueil des Travaux Chimiques des Pays-Bas, 1901, vol. 20, p. 169
[2] Chemische Berichte, 1883, vol. 16, p. 1959[3] Chemische Berichte, 1884, vol. 17, p. 164
[4] Chemische Berichte, 1884, vol. 17, p. 161
[5] Justus Liebigs Annalen der Chemie, 1870, vol. 156, p. 235
[6] Justus Liebigs Annalen der Chemie, 1873, vol. 168, p. 246
[7] Chemische Berichte, 1883, vol. 16, p. 1959[8] Chemische Berichte, 1884, vol. 17, p. 164
[9] Gazzetta Chimica Italiana, 1935, vol. 65, p. 840,842
[10] Chemische Berichte, 1883, vol. 16, p. 1959[11] Chemische Berichte, 1884, vol. 17, p. 164
[12] Tetrahedron Letters, 2002, vol. 43, # 27, p. 4789 - 4791
[13] Tetrahedron Letters, 2008, vol. 49, # 28, p. 4449 - 4451
[14] Tetrahedron Letters, 2011, vol. 52, # 13, p. 1452 - 1455
  • 3
  • [ 1975-52-6 ]
  • [ 16634-91-6 ]
Reference: [1] Patent: US2003/73850, 2003, A1,
[2] Patent: US2015/218086, 2015, A1,
[3] Patent: WO2017/24009, 2017, A1,
  • 4
  • [ 99-51-4 ]
  • [ 7697-37-2 ]
  • [ 1975-51-5 ]
  • [ 1975-52-6 ]
Reference: [1] Chemische Berichte, 1884, vol. 17, p. 161
  • 5
  • [ 77324-87-9 ]
  • [ 1975-52-6 ]
YieldReaction ConditionsOperation in experiment
98% With lithium hydroxide; water In tetrahydrofuran at 30℃; for 4 h; To a solution of compound 3 (75.0 g, 0.46 mol) in THF (500 mL) was added 1 N aq. LiOH (1 L, 0.92 mol), then the mixture was stirred at 30°Cfor 4 hours. TLC (petroleum ether: ethyl acetate = 10:1 ) showed the reaction was complete, then the mixture was concentrated in vacuo and the residue was extracted with ethyl acetate (200 mLx2). The combined organic layers were washed with brine, dried over anhydrous sodium sulfate and concentrated in vacuo to give compound 4 (67 g, 98percent) as a brown solid., which was used in the next step without further purification. 1H NMR (400 MHz, CDCI3): δ 8.93 (S, 1 H), 8.30-8.32 (d, J = 8.0 Hz, 1 H), 7.48- 7.50 (d, J = 8.0 Hz, 1 H), 2.79 (s, 3H).
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2008, vol. 18, # 23, p. 6273 - 6278
[2] Patent: WO2006/117669, 2006, A1, . Location in patent: Page/Page column 41; 114
[3] Organic letters, 2000, vol. 2, # 19, p. 2931 - 2934
  • 6
  • [ 118-90-1 ]
  • [ 1975-50-4 ]
  • [ 1975-52-6 ]
Reference: [1] Recueil des Travaux Chimiques des Pays-Bas, 1901, vol. 20, p. 169
[2] Chemische Berichte, 1883, vol. 16, p. 1959[3] Chemische Berichte, 1884, vol. 17, p. 164
[4] Chemische Berichte, 1884, vol. 17, p. 161
[5] Justus Liebigs Annalen der Chemie, 1870, vol. 156, p. 235
[6] Justus Liebigs Annalen der Chemie, 1873, vol. 168, p. 246
[7] Chemische Berichte, 1883, vol. 16, p. 1959[8] Chemische Berichte, 1884, vol. 17, p. 164
[9] Gazzetta Chimica Italiana, 1935, vol. 65, p. 840,842
[10] Chemische Berichte, 1883, vol. 16, p. 1959[11] Chemische Berichte, 1884, vol. 17, p. 164
[12] Tetrahedron Letters, 2002, vol. 43, # 27, p. 4789 - 4791
[13] Tetrahedron Letters, 2008, vol. 49, # 28, p. 4449 - 4451
[14] Tetrahedron Letters, 2011, vol. 52, # 13, p. 1452 - 1455
  • 7
  • [ 99-51-4 ]
  • [ 1975-52-6 ]
Reference: [1] Chemical Communications, 1998, # 1, p. 73 - 74
  • 8
  • [ 118-90-1 ]
  • [ 1975-52-6 ]
Reference: [1] Journal of Medicinal Chemistry, 2007, vol. 50, # 15, p. 3420 - 3422
[2] Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, # 17, p. 5004 - 5008
  • 9
  • [ 7745-93-9 ]
  • [ 1975-52-6 ]
Reference: [1] Patent: WO2006/117669, 2006, A1,
  • 10
  • [ 939-83-3 ]
  • [ 1975-52-6 ]
Reference: [1] Journal of the Indian Chemical Society, 1937, vol. 14, p. 144,150
[2] Patent: WO2006/117669, 2006, A1,
  • 11
  • [ 529-19-1 ]
  • [ 1975-52-6 ]
Reference: [1] Justus Liebigs Annalen der Chemie, 1873, vol. 168, p. 246
  • 12
  • [ 95-47-6 ]
  • [ 1975-52-6 ]
Reference: [1] Justus Liebigs Annalen der Chemie, 1870, vol. 156, p. 235
  • 13
  • [ 619-04-5 ]
  • [ 1975-52-6 ]
Reference: [1] Justus Liebigs Annalen der Chemie, 1870, vol. 156, p. 235
  • 14
  • [ 89-71-4 ]
  • [ 59382-59-1 ]
  • [ 1975-52-6 ]
Reference: [1] Recueil des Travaux Chimiques des Pays-Bas, 1901, vol. 20, p. 169
  • 15
  • [ 99-51-4 ]
  • [ 7697-37-2 ]
  • [ 1975-51-5 ]
  • [ 1975-52-6 ]
Reference: [1] Chemische Berichte, 1884, vol. 17, p. 161
  • 16
  • [ 1975-52-6 ]
  • [ 74-88-4 ]
  • [ 77324-87-9 ]
YieldReaction ConditionsOperation in experiment
98% With potassium carbonate In DMF (N,N-dimethyl-formamide) at 20℃; A solution of 2-methyl-5-nitrobenzoic acid (15 g, 82.8 mmole) in DMF (75 mL) was treated with methyl iodide (6.7 mL, 107.64 mmole) followed by powdered K2CO3 (17.2 g, 124.2 mmole) (extreme exotherm) and the suspension stirred at ambient temperature overnight. The reaction mixture was partitioned between EtOAc and water, the organics separated and washed with water and brine, dried (Na2SO4) and concentrated in vacuo to yield K1 (15.86 g, 98percent) in pure form as an off-white solid. The 1H NMR was consistent with that of the desired structure.
94% With potassium carbonate In N,N-dimethyl-formamide at 20℃; 4.2.1
Methyl-2-methyl-5-nitrobenzoate (2)
To a mixture of 2-methyl-5-nitrobenzoic acid (15 g, 82.8 mmol) and K2CO3 (17.2 g, 124.2 mmol) in 75 mL DMF was added iodomethane (6.7 mL).
The mixture was stirred at room temperature overnight.
Then, 500 mL water was added into the mixture, the aqueous phase was extracted with EA for three times.
The combined organic phase was dried with Na2SO4, concentrated to afford the product 2 (15.3 g, 94percent) as yellow solid. 1H NMR (400 MHz, CDCl3) δ 8.52 (s, 1H), 8.05 (s, 1H), 7.30 (s, 1H), 3.83 (s, 3H), 2.56 (s, 3H). ESI-MS m/z 196 [M+H]+.
Reference: [1] Journal of the American Chemical Society, 2003, vol. 125, # 40, p. 12074 - 12075
[2] Patent: US6344465, 2002, B1, . Location in patent: Page column 32
[3] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 17, p. 5881 - 5890
[4] Patent: US2005/43385, 2005, A1, . Location in patent: Page/Page column 14
[5] Patent: US2001/34343, 2001, A1,
[6] Patent: US5861417, 1999, A,
[7] Patent: EP946548, 2002, B1,
[8] Patent: US6194406, 2001, B1,
[9] Patent: US6423704, 2002, B1,
[10] Patent: US6211199, 2001, B1,
  • 17
  • [ 67-56-1 ]
  • [ 1975-52-6 ]
  • [ 77324-87-9 ]
YieldReaction ConditionsOperation in experiment
99% at 0℃; Reflux 2-Methyl-5-nitrobenzoic Acid Methyl Ester (35). To a stirring MeOH (4 mL) in a round-bottom flask was added dropwise thionyl chloride (0.24 mL, 3.3 mmol) at 0° C. The mixture was added 2-methyl-5-nitrobenzoic acid 34 (300 mg, 1.7 mmol) at 0° C. and it was allowed to stir for 4 h at reflux temperature. The reaction was concentrated under reduced pressure, and the residue was purified by silica gel column chromatography to give corresponding compound 35 (320 mg, 99percent) as a colorless oil, Rf=0.85 (hexane:EtOAc=1:1). 1H NMR (400 MHz, CDCl3): δ 8.52 (s, 1H), 8.05 (s, 1H), 7.30 (s, 1H), 3.83 (s, 3H), 2.56 (s, 3H). 13CNMR(100 MHz, CDCl3): δ 165.4, 147.6, 145.6, 132.5, 130.1, 125.8, 125.3, 52.1, 21.5. MS (EI): m/z 195 [M]+. HRMS (EI), calcd for C9H9N04195.0532, found [M]+ 195.0539.
87% for 36 h; Heating / reflux 2-Methyl-5-nitrobenzoate (5.0 g, 27.6 mmol) was dissolved in [MEOH] (0.4 L) followed by the addition of H2SO4 (7 mL). The mixture was heated at reflux for 36 h, then cooled [TO RT] and concentrated to ca 100 mL. The solution was diluted with [MTBE] neutralized with 6N [NAOH,] washed with 1N [NAOH,] brine, dried [(MGS04),] filtered and concentrated in vacuo to afford 4.72 g (87percent) of methyl [2-METHYL-5-NITROBENZOATE] as a white solid.
Reference: [1] Journal of Medicinal Chemistry, 2009, vol. 52, # 16, p. 5228 - 5240
[2] Patent: US2011/269834, 2011, A1, . Location in patent: Page/Page column 28-29
[3] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 10, p. 2823 - 2827
[4] Patent: WO2004/18414, 2004, A2, . Location in patent: Page 109-110
[5] Journal of Medicinal Chemistry, 2013, vol. 56, # 21, p. 8561 - 8578
[6] European Journal of Medicinal Chemistry, 1991, vol. 26, # 7, p. 699 - 707
[7] Patent: WO2005/80388, 2005, A1, . Location in patent: Page/Page column 55
[8] Patent: WO2006/63805, 2006, A1, . Location in patent: Page/Page column 75
[9] Patent: WO2007/71955, 2007, A1, . Location in patent: Page/Page column 52
[10] Patent: US2009/239859, 2009, A1, . Location in patent: Page/Page column 298
[11] Patent: WO2005/9940, 2005, A1, . Location in patent: Page 174
[12] Patent: US2010/81643, 2010, A1, . Location in patent: Page/Page column 37
[13] Patent: WO2010/47982, 2010, A1, . Location in patent: Page/Page column 77-78
[14] Journal of Medicinal Chemistry, 2011, vol. 54, # 2, p. 635 - 654
[15] Patent: WO2014/167444, 2014, A1, . Location in patent: Page/Page column 46; 47
[16] Patent: WO2016/90079, 2016, A1, . Location in patent: Paragraph 00883-00884
  • 18
  • [ 1975-52-6 ]
  • [ 77324-87-9 ]
Reference: [1] Patent: US2003/212094, 2003, A1,
[2] Patent: EP514133, 1992, A1,
[3] ACS Medicinal Chemistry Letters, 2016, vol. 7, # 12, p. 1077 - 1081
  • 19
  • [ 186581-53-3 ]
  • [ 1975-52-6 ]
  • [ 77324-87-9 ]
Reference: [1] Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry, 1984, vol. 23, # 11, p. 1098 - 1102
  • 20
  • [ 1975-52-6 ]
  • [ 90725-68-1 ]
Reference: [1] European Journal of Medicinal Chemistry, 1991, vol. 26, # 7, p. 699 - 707
[2] Patent: US2011/269834, 2011, A1,
[3] Journal of Medicinal Chemistry, 2013, vol. 56, # 21, p. 8561 - 8578
[4] Patent: WO2016/90079, 2016, A1,
  • 21
  • [ 1975-52-6 ]
  • [ 103440-54-6 ]
Reference: [1] Patent: WO2006/117669, 2006, A1,
  • 22
  • [ 1975-52-6 ]
  • [ 54811-38-0 ]
Reference: [1] Patent: WO2006/117669, 2006, A1,
  • 23
  • [ 1975-52-6 ]
  • [ 18595-12-5 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 10, p. 2823 - 2827
[2] Journal of the American Chemical Society, 2003, vol. 125, # 40, p. 12074 - 12075
[3] Journal of Medicinal Chemistry, 2011, vol. 54, # 2, p. 635 - 654
[4] Patent: US2011/269834, 2011, A1,
  • 24
  • [ 1975-52-6 ]
  • [ 2840-04-2 ]
YieldReaction ConditionsOperation in experiment
96% With hydrogen In methanol at 40℃; for 3 - 4 h; A mixture of compound 4 (30.0 g, 0.166 mol) and Pd/C (1.8 g) in dry methanol (1600 mL) was stirred under 50 Psi of H2 at 40sC for 3 to 4 hours. TLC (petroleum ether: ethyl acetate = 1 :2) showed the reaction was complete, then the mixture was filtered and the filtrate was concentrated in vacuo to give compound 5 (24 g, 96percent) as a white solid. 1H NMR (400 MHz, CDCI3): δ 7.10 (S, 1H), 6.89-6.91 (d, J = 8.0 Hz, 1 H), 6.64-6.66 (dd, J = 8.0 Hz, 1H), 2.31 (s, 3H).
95% With 5%-palladium/activated carbon; hydrogen In ethanolFlow reactor General procedure: Before each run, the system (see Fig.4) was allowed to equilibrate by pumping solvent through for 30min with the Tube-in-Tube device at 16bar of hydrogen. An omnifit cartridge (20.0mm OD, 15.0mm ID) containing 1g of Pd-C catalyst was used. To avoid an overpressure of the system in the event of blockage, the upper pressure cut-off limit on the Knauer pump was set to 25bar. With the injection loop disconnected from the flow line, the loop was opened and filled manually (using a syringe) with 3.6mL of a 0.076M solution of starting material in ethanol (excess starting material solution exiting the loop was recovered for reuse). The injection loop was then closed off and switched into the flow stream. The outlet from the system (downstream of the back-pressure regulator) was collected for 120min. The solvent was removed under reduced pressure (using a rotary evaporator followed by a 2-stage rotary vane pump) to afford the product.
Reference: [1] Journal of Medicinal Chemistry, 1996, vol. 39, # 17, p. 3343 - 3356
[2] Bioorganic and Medicinal Chemistry Letters, 2008, vol. 18, # 23, p. 6273 - 6278
[3] Patent: WO2006/117669, 2006, A1, . Location in patent: Page/Page column 41; 114
[4] Tetrahedron, 2018, vol. 74, # 47, p. 6795 - 6803
[5] Chemische Berichte, 1883, vol. 16, p. 1959[6] Chemische Berichte, 1884, vol. 17, p. 164
[7] Bulletin de la Societe Scientifique de Bretagne, 1956, vol. 31, p. Sonderheft S.9,41
[8] Bulletin de la Societe Chimique de France, 1966, p. 1848 - 1858
[9] Journal of Organic Chemistry, 1988, vol. 53, # 1, p. 98 - 104
[10] Tetrahedron Letters, 1991, vol. 32, # 39, p. 5379 - 5382
[11] Patent: EP2103620, 2009, A1, . Location in patent: Page/Page column 67
[12] Patent: WO2010/55083, 2010, A1, . Location in patent: Page/Page column 108
[13] Patent: US2007/72862, 2007, A1, . Location in patent: Page/Page column 70-71
[14] Journal of Medicinal Chemistry, 2013, vol. 56, # 21, p. 8561 - 8578
[15] Patent: CN106083601, 2016, A, . Location in patent: Paragraph 0075-0078
  • 25
  • [ 1975-52-6 ]
  • [ 98799-27-0 ]
Reference: [1] ACS Medicinal Chemistry Letters, 2014, vol. 5, # 5, p. 527 - 532
[2] Journal of Medicinal Chemistry, 2014, vol. 57, # 10, p. 3939 - 3965
[3] Patent: US2015/218086, 2015, A1,
[4] Patent: US2016/376238, 2016, A1,
[5] Patent: WO2017/24009, 2017, A1,
  • 26
  • [ 1975-52-6 ]
  • [ 850449-93-3 ]
Reference: [1] Patent: WO2009/105712, 2009, A1,
[2] Patent: WO2005/34869, 2005, A2,
  • 27
  • [ 1975-52-6 ]
  • [ 287119-83-9 ]
Reference: [1] Patent: WO2009/105712, 2009, A1,
  • 28
  • [ 1975-52-6 ]
  • [ 421551-82-8 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 10, p. 2823 - 2827
  • 29
  • [ 1975-52-6 ]
  • [ 885519-05-1 ]
Reference: [1] ACS Medicinal Chemistry Letters, 2018, vol. 9, # 2, p. 98 - 102
[2] Patent: EP3378859, 2018, A1,
  • 30
  • [ 1975-52-6 ]
  • [ 788081-99-2 ]
Reference: [1] Journal of Medicinal Chemistry, 2013, vol. 56, # 21, p. 8561 - 8578
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 1975-52-6 ]

Aryls

Chemical Structure| 6954-70-7

[ 6954-70-7 ]

2,5-Dimethyl-4-nitrobenzoic acid

Similarity: 0.98

Chemical Structure| 3807-81-6

[ 3807-81-6 ]

5-Nitrobenzene-1,2,3-tricarboxylic acid

Similarity: 0.98

Chemical Structure| 220504-75-6

[ 220504-75-6 ]

2,4-Dimethyl-5-nitrobenzoic acid

Similarity: 0.98

Chemical Structure| 3898-66-6

[ 3898-66-6 ]

2-(Carboxymethyl)-5-nitrobenzoic acid

Similarity: 0.97

Chemical Structure| 39585-32-5

[ 39585-32-5 ]

2-(Carboxymethyl)-4-nitrobenzoic acid

Similarity: 0.97

Carboxylic Acids

Chemical Structure| 6954-70-7

[ 6954-70-7 ]

2,5-Dimethyl-4-nitrobenzoic acid

Similarity: 0.98

Chemical Structure| 3807-81-6

[ 3807-81-6 ]

5-Nitrobenzene-1,2,3-tricarboxylic acid

Similarity: 0.98

Chemical Structure| 220504-75-6

[ 220504-75-6 ]

2,4-Dimethyl-5-nitrobenzoic acid

Similarity: 0.98

Chemical Structure| 39585-32-5

[ 39585-32-5 ]

2-(Carboxymethyl)-4-nitrobenzoic acid

Similarity: 0.97

Chemical Structure| 20246-81-5

[ 20246-81-5 ]

4,4'-Dinitro-[1,1'-biphenyl]-2,2'-dicarboxylic acid

Similarity: 0.95

Nitroes

Chemical Structure| 6954-70-7

[ 6954-70-7 ]

2,5-Dimethyl-4-nitrobenzoic acid

Similarity: 0.98

Chemical Structure| 3807-81-6

[ 3807-81-6 ]

5-Nitrobenzene-1,2,3-tricarboxylic acid

Similarity: 0.98

Chemical Structure| 220504-75-6

[ 220504-75-6 ]

2,4-Dimethyl-5-nitrobenzoic acid

Similarity: 0.98

Chemical Structure| 39585-32-5

[ 39585-32-5 ]

2-(Carboxymethyl)-4-nitrobenzoic acid

Similarity: 0.97

Chemical Structure| 20246-81-5

[ 20246-81-5 ]

4,4'-Dinitro-[1,1'-biphenyl]-2,2'-dicarboxylic acid

Similarity: 0.95